Active Not RecruitingNCT06791122
This study is active but not recruiting in the United States. It is testing an Investigational Digital Therapeutic for schizophrenia.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Boehringer Ingelheim
- Condition
- Schizophrenia
CompletedNCT02250339
This study is completed. It focuses on ADHD and currently lists study information in Finland.
ADHDOtherFrom 5 Years to 12 Years
- Countries
- Finland
- Sponsor
- Social Insurance Institution, Finland
- Condition
- ADHD
TerminatedNCT02446509
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
- Condition
- Bipolarity
CompletedNCT04020289
This study is completed. It focuses on bipolarity and currently lists study information in Global.
BipolarityOtherFrom 20 Years to 65 Years
- Countries
- Global
- Sponsor
- National Cheng Kung University
- Condition
- Bipolarity
CompletedNCT04186312
This study is completed. It focuses on ADHD and currently lists study information in Global.
ADHDOtherFrom 18 Years to 30 Years
- Countries
- Global
- Sponsor
- University of North Carolina, Greensboro
- Condition
- ADHD
OngoingEUCTR 2022-003743-10
This study is ongoing in Germany, in Poland, and in Spain. It is testing Intranasal BPL-003, with Open Label Extension, for depression.
DepressionOther
- Countries
- Germany, Poland, Spain
- Sponsor
- Beckley Psytech Ltd.
- Condition
- Depression
CompletedNCT07100548
This study is completed. It focuses on depression and currently lists study information in Germany.
DepressionOtherFrom 13 Years to 18 Years
- Countries
- Germany
- Sponsor
- Ludwig-Maximilians - University of Munich
- Condition
- Depression
OngoingEUCTR 2018-002942-35
This study is ongoing in the United Kingdom. It focuses on depression.
DepressionOther
- Countries
- United Kingdom
- Sponsor
- University College London Comprehensive Clinical Trials Unit
- Condition
- Depression
OngoingEUCTR 2015-003957-16
This study is ongoing in Netherlands. It focuses on depression.
DepressionOther
- Countries
- Netherlands
- Sponsor
- University Medical Centre Groningen
- Condition
- Depression
OngoingEUCTR 2016-000118-31
This study is ongoing in the United Kingdom. It focuses on Schizophrenia.
SchizophreniaOther
- Countries
- United Kingdom
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge
- Condition
- Schizophrenia
OngoingEUCTR 2016-001637-27
This study is ongoing in the United Kingdom. It is testing lithium and quetiapine augmentation for depression.
DepressionOther
- Countries
- United Kingdom
- Sponsor
- South London and Maudsley NHS Foundation Trust [...] 1. South London and Maudsley NHS Foundation Trust 2. King's College London
- Condition
- Depression
OngoingEUCTR 2020-000469-18
This study is ongoing in the United Kingdom. It is testing IP2018 for Depression.
DepressionOther
- Countries
- United Kingdom
- Sponsor
- Initiator Pharma
- Condition
- Depression
